Advanced Wounds
Aeris provides the biomaterials required to transform biofilm-stalled wounds into regenerative environments by mimicking the breathable, open-cell architecture of the body’s natural extracellular matrix.
REGENERATION BEGINS AT THE SURFACE
The race to heal is won at the interface. Aeris engineers porous biomaterials with micro- and nanoscale hierarchical architectures that actively organize biology, promoting regenerative cell integration while preventing biofilms.
Engineering the architecture of human regeneration.
Every year,
million
People worldwide develop bacterial infections.
Across these infections,
%
Are associated with microbial biofilms.
This is not just a medical failure; it is a failure of material design. Standard biomaterials are passive, serving as reservoirs for bacterial colonization and forcing reactive, post-infection care.
Our Aer™ biomaterials redefine the role of materials through controlled surface chemistry and three-dimensional architecture, promoting tissue integration while resisting biofilm at the source.
We don’t just treat infection.
We engineer biomaterials that prevent it.
Structure Heals.
We Provide the Framework
As the body’s blueprint for tissue organization, the extracellular matrix is essential for regeneration. Aer™ mimics this framework to provide a tunable, bio-instructive environment that supports healing and prevents biofilms while serving as a platform that can also monitor tissue health and deliver therapeutics.
Bone Regeneration
Aeris engineers the porous structural and chemical framework for bone regeneration, ensuring seamless osteointegration while eliminating the risk of periprosthetic infection.
Medical Implants
We design the critical boundary of medical implants to actively prevent biofilm formation while providing the molecular docking sites necessary for rapid, stable cell growth.
Architecting a resilient future for human health
To secure a resilient future for human health, our materials must evolve alongside our clinical standards. By architecting biomaterials that provide the physical framework for repair, we build a scalable foundation for tissue regeneration and infection prevention. This intentional approach moves healthcare from reactive treatment to a future of predictable, human-centered recovery.
Partners
